| Motif ID |
Motif Logo |
Scanned Score Distribution |
Frequency of Motif |
Replicability Score |
Evolutionary Conservation Score |
Gene Targets |
Gene Ontology of CpGMM targets |
| CG_ffipsc197_promoter_p_RM_12_114_12 |
 |
 |
7 |
1.0 |
3.11E-04 |
PTF1A,
SMAD6,
ZNF844,
C11orf30,
LIN28B,
DNAJC10,
GLRX5,
EPCAM,
CCNK,
ARID3A |
ureteric bud development [BP],
regulation of transcription, DNA-dependent [BP],
protein disulfide oxidoreductase activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_111_4 |
 |
 |
3 |
0.6 |
2.61E-04 |
CHD7 |
skeletal system development [BP] |
| CG_ffipsc197_promoter_p_RM_12_42_7 |
 |
 |
4 |
0.6 |
3.30E-04 |
NT5E,
VEGFA,
MOG |
adenosine biosynthetic process [BP],
basophil chemotaxis [BP],
positive regulation of MyD88-dependent toll-like receptor signaling pathway [BP] |
| CG_ffipsc197_promoter_p_RM_12_275_4 |
 |
 |
2 |
0.4 |
2.74E-04 |
ADO,
CDH3,
RUFY3,
NRTN,
ABI2 |
filopodium [CC],
neuron projection development [BP],
cysteamine dioxygenase activity [MF],
cell-cell adherens junction [CC] |
| CG_ffipsc197_promoter_p_RM_12_268_7 |
 |
 |
4 |
0.8 |
3.35E-04 |
UHRF1 |
hemi-methylated DNA-binding [MF] |
| CG_ffipsc197_promoter_p_RM_12_6_4 |
 |
 |
2 |
0.4 |
3.51E-04 |
CCND2,
FZD7,
CAB39,
ATG13,
CCNK,
SQSTM1 |
positive regulation of phosphorylation [BP],
positive regulation of cyclin-dependent protein kinase activity [BP],
regulation of cyclin-dependent protein kinase activity [BP],
cyclin-dependent protein kinase holoenzyme complex [CC],
pre-autophagosomal structure [CC],
kinase binding [MF] |
| CG_ffipsc197_promoter_p_RM_12_89_5 |
 |
 |
5 |
0.8 |
4.66E-04 |
SUN1 |
nuclear matrix anchoring at nuclear membrane [BP] |
| CG_ffipsc197_promoter_p_RM_12_30_11 |
 |
 |
4 |
0.8 |
2.81E-04 |
PABPN1 |
modulation by virus of host cellular process [BP] |
| CG_ffipsc197_promoter_p_RM_14_25_4 |
 |
 |
3 |
0.4 |
4.94E-04 |
FOXG1 |
regulation of sequence-specific DNA binding transcription factor activity [BP] |
| CG_ffipsc197_promoter_p_RM_14_27_4 |
 |
 |
8 |
1.0 |
5.08E-04 |
CEBPB,
ARID1A,
VIL1,
BMPR2,
MMP2,
CCDC64 |
cytoplasmic actin-based contraction involved in cell motility [BP],
nucleosome mobilization [BP],
cellular response to amino acid stimulus [BP],
positive regulation of epithelial cell migration [BP],
Golgi to secretory granule transport [BP] |
| CG_ffipsc197_promoter_p_RM_12_155_10 |
 |
 |
6 |
0.8 |
3.69E-04 |
DOCK1,
RHBDD1,
EGLN2 |
phagocytosis, engulfment [BP],
positive regulation of protein catabolic process [BP] |
| CG_ffipsc197_promoter_p_RM_12_95_6 |
 |
 |
2 |
0.4 |
2.59E-04 |
RUSC1,
KIF26A,
CCT7,
SOX8 |
enteric nervous system development [BP],
microtubule [CC] |
| CG_ffipsc197_promoter_p_RM_12_191_8 |
 |
 |
3 |
0.6 |
3.10E-04 |
UBE2E3,
YY1 |
camera-type eye morphogenesis [BP],
protein K63-linked ubiquitination [BP] |
| CG_ffipsc197_promoter_p_RM_12_1_4 |
 |
 |
4 |
0.8 |
2.65E-04 |
NT5M |
dUMP catabolic process [BP] |
| CG_ffipsc197_promoter_p_RM_14_18_4 |
 |
 |
7 |
0.8 |
3.34E-04 |
FGFR3 |
bone maturation [BP] |
| CG_ffipsc197_promoter_p_RM_12_220_7 |
 |
 |
6 |
1.0 |
3.57E-04 |
HPN,
CTCF,
KCNT1 |
regulation of gene expression, epigenetic [BP],
potassium ion transmembrane transport [BP],
basement membrane disassembly [BP],
calcium-activated potassium channel activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_116_3 |
 |
 |
2 |
0.4 |
3.46E-04 |
KDM3A,
RHBDD1,
MAN1B1 |
formaldehyde biosynthetic process [BP],
ER-associated protein catabolic process [BP],
endoplasmic reticulum quality control compartment [CC],
histone H3-K9 dimethylation [BP] |
| CG_ffipsc197_promoter_p_RM_12_161_6 |
 |
 |
6 |
1.0 |
2.98E-04 |
SOX11 |
positive regulation of lens epithelial cell proliferation [BP],
positive regulation of hippo signaling cascade [BP] |
| CG_ffipsc197_promoter_p_RM_12_183_4 |
 |
 |
5 |
0.8 |
2.68E-04 |
MAPKAPK3,
MAP2K3 |
MAP kinase kinase activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_77_4 |
 |
 |
3 |
0.6 |
1.76E-04 |
PRKCG,
MIF,
NAGK |
N-acetylglucosamine kinase activity [MF],
positive regulation of mismatch repair [BP],
phenylpyruvate tautomerase activity [MF],
positive regulation of prostaglandin secretion involved in immune response [BP] |
| CG_ffipsc197_promoter_p_RM_12_127_11 |
 |
 |
5 |
1.0 |
3.28E-04 |
STK4,
P2RX4,
EDNRA |
hippo signaling cascade [BP],
histamine secretion [BP],
positive regulation of calcium ion transport into cytosol [BP] |
| CG_ffipsc197_promoter_p_RM_12_277_9 |
 |
 |
4 |
0.8 |
3.29E-04 |
OGG1,
ARHGEF1,
GRK5 |
oxidized purine nucleobase lesion DNA N-glycosylase activity [MF],
8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [MF],
termination of G-protein coupled receptor signaling pathway [BP] |
| CG_ffipsc197_promoter_p_RM_12_236_17 |
 |
 |
7 |
1.0 |
3.24E-04 |
TGFBR2,
SPHK1,
LRP5,
HIPK1,
TNFRSF11A,
IKZF1,
GAD1,
PROSC,
MARC2 |
embryonic retina morphogenesis in camera-type eye [BP],
tumor necrosis factor-mediated signaling pathway [BP],
regulation of tumor necrosis factor-mediated signaling pathway [BP],
pyridoxal phosphate binding [MF],
positive regulation of NK T cell differentiation [BP] |
| CG_ffipsc197_promoter_p_RM_12_157_6 |
 |
 |
3 |
0.6 |
1.78E-04 |
PBX3,
HTRA2,
PPP2R1A |
peptidyl-serine dephosphorylation [BP],
pentacyclic triterpenoid metabolic process [BP],
adult locomotory behavior [BP],
anterior compartment pattern formation [BP],
ceramide metabolic process [BP],
posterior compartment specification [BP] |
| CG_ffipsc197_promoter_p_RM_12_184_11 |
 |
 |
3 |
0.6 |
2.95E-04 |
SOX11,
PFKP,
SLC5A2,
DCAF17,
FBXO25,
RBX1,
HES1,
XYLB,
CSGALNACT2,
RTN4RL2,
NTNG2 |
anchored to plasma membrane [CC],
carbohydrate metabolic process [BP],
glial cell proliferation [BP],
SCF ubiquitin ligase complex [CC],
Cul4-RING ubiquitin ligase complex [CC],
negative regulation of glial cell proliferation [BP],
cullin-RING ubiquitin ligase complex [CC] |
| CG_ffipsc197_promoter_p_RM_12_23_7 |
 |
 |
5 |
1.0 |
1.73E-05 |
POLR2F,
GPATCH1,
EIF4A2 |
mRNA metabolic process [BP],
mRNA splicing, via spliceosome [BP] |
| CG_ffipsc197_promoter_p_RM_12_71_6 |
 |
 |
4 |
0.8 |
3.00E-04 |
BHLHE40,
SREBF2 |
E-box binding [MF] |
| CG_ffipsc197_promoter_p_RM_14_26_9 |
 |
 |
7 |
1.0 |
5.26E-04 |
CXADR,
KCNC4 |
neuromuscular junction [CC] |
| CG_ffipsc197_promoter_p_RM_12_106_4 |
 |
 |
4 |
0.8 |
4.31E-04 |
PPP2R1A,
GNAS,
FOXQ1 |
peptidyl-serine dephosphorylation [BP],
embryo development [BP],
post-embryonic body morphogenesis [BP] |
| CG_ffipsc197_promoter_p_RM_14_23_2 |
 |
 |
2 |
0.4 |
2.61E-04 |
PTK2B |
3-phosphoinositide-dependent protein kinase binding [MF] |
| CG_ffipsc197_promoter_p_RM_14_4_5 |
 |
 |
13 |
1.0 |
5.04E-04 |
MAP2K1,
SLC30A5,
PRPF3,
SMG7,
CDC73,
ZNF703,
PDE1B,
SLIT2,
CAMTA1,
MVP,
SIRT1,
GREM1,
NR4A3,
SENP2,
CASC3,
PPARD,
PKNOX2,
NAA15,
SUPT6H,
YBX1,
RING1,
CXXC5,
ZMIZ1,
MMP2,
PSKH1,
ZNF292,
AFTPH |
regulation of DNA-dependent transcription, elongation [BP],
mRNA transport [BP],
negative regulation of homotypic cell-cell adhesion [BP],
bone trabecula formation [BP],
nuclear speck [CC],
nucleoplasm [CC],
negative regulation of monocyte chemotaxis [BP],
negative regulation of leukocyte chemotaxis [BP],
positive regulation of transcription elongation from RNA polymerase II promoter [BP],
nucleus [CC] |
| CG_ffipsc197_promoter_p_RM_12_108_5 |
 |
 |
2 |
0.4 |
3.23E-04 |
PPM1A,
NPEPL1,
FOXO3,
VEGFA,
SART1,
FGF2,
RREB1,
FZD1 |
positive regulation of blood vessel endothelial cell migration [BP],
chemoattractant activity [MF],
negative regulation of transcription, DNA-dependent [BP],
manganese ion binding [MF],
positive regulation of transcription, DNA-dependent [BP],
ovarian follicle development [BP],
gonad development [BP],
basophil chemotaxis [BP],
initiation of primordial ovarian follicle growth [BP],
positive regulation of endothelial cell proliferation [BP],
insulin receptor signaling pathway [BP],
lung development [BP],
positive regulation of endothelial cell migration [BP],
cell migration involved in sprouting angiogenesis [BP],
outflow tract morphogenesis [BP],
positive regulation of cytotoxic T cell differentiation [BP],
positive chemotaxis [BP],
positive regulation of gene expression [BP] |
| CG_ffipsc197_promoter_p_RM_12_79_5 |
 |
 |
5 |
0.6 |
2.81E-04 |
PGS1,
AGPAT6 |
diacylglycerol metabolic process [BP] |
| CG_ffipsc197_promoter_p_RM_14_21_2 |
 |
 |
3 |
0.4 |
2.66E-04 |
CDS2,
SRR |
D-serine biosynthetic process [BP],
D-serine ammonia-lyase activity [MF],
threonine racemase activity [MF],
L-serine ammonia-lyase activity [MF],
D-serine metabolic process [BP],
serine racemase activity [MF],
phosphatidate cytidylyltransferase activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_246_6 |
 |
 |
7 |
0.8 |
2.30E-04 |
UTS2R,
ZFYVE27,
RAB12 |
recycling endosome [CC],
recycling endosome membrane [CC] |
| CG_ffipsc197_promoter_p_RM_12_136_7 |
 |
 |
4 |
0.8 |
2.64E-04 |
SPR,
ACADS,
CBX3,
TRIM24 |
butyrate catabolic process [BP],
sepiapterin reductase activity [MF],
butyryl-CoA dehydrogenase activity [MF],
nuclear euchromatin [CC] |
| CG_ffipsc197_promoter_p_RM_14_10_3 |
 |
 |
5 |
0.8 |
3.07E-04 |
CNNM2,
ADHFE1,
PCYOX1 |
chloride-transporting ATPase activity [MF],
prenylcysteine catabolic process [BP],
magnesium ion homeostasis [BP],
prenylcysteine metabolic process [BP],
prenylated protein catabolic process [BP],
hydroxyacid-oxoacid transhydrogenase activity [MF],
molecular hydrogen transport [BP],
prenylcysteine oxidase activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_234_7 |
 |
 |
3 |
0.4 |
2.69E-04 |
TRIM28,
MIB2,
RNF182,
STUB1 |
ubiquitin-protein ligase activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_230_10 |
 |
 |
5 |
0.8 |
2.95E-04 |
ING3,
PHF2,
ING2,
KIT,
LYN |
receptor signaling protein tyrosine kinase activity [MF],
mast cell proliferation [BP],
methylated histone residue binding [MF],
signal transduction by phosphorylation [BP] |
| CG_ffipsc197_promoter_p_RM_12_25_4 |
 |
 |
3 |
0.6 |
3.70E-04 |
BMPR2,
GATA3,
NGFR,
SPHK1 |
positive regulation of fibroblast proliferation [BP],
negative regulation of fibroblast growth factor receptor signaling pathway [BP],
negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation [BP],
regulation of cell proliferation [BP],
negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation [BP],
negative regulation of cell proliferation involved in mesonephros development [BP],
positive regulation of endothelial cell migration [BP],
regulation of histone H3-K27 methylation [BP],
sphingoid catabolic process [BP] |
| CG_ffipsc197_promoter_p_RM_12_75_11 |
 |
 |
5 |
1.0 |
2.98E-04 |
WTIP,
CYLD,
FSCN2,
EPB49,
ITSN1 |
proline-rich region binding [MF],
cytoskeleton organization [BP],
actin filament bundle assembly [BP] |
| CG_ffipsc197_promoter_p_RM_12_158_7 |
 |
 |
3 |
0.6 |
1.98E-04 |
HBQ1,
MTRR,
MSMO1 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [MF],
iron ion binding [MF],
[methionine synthase] reductase activity [MF],
C-4 methylsterol oxidase activity [MF] |
| CG_ffipsc197_promoter_p_RM_14_6_2 |
 |
 |
5 |
0.8 |
3.15E-04 |
ACSL3,
YY1,
SUV420H2,
RIPK1 |
positive regulation of phosphatidylcholine biosynthetic process [BP],
condensed nuclear chromosome, centromeric region [CC],
regulation of ATP:ADP antiporter activity [BP],
response to prostaglandin F stimulus [BP] |
| CG_ffipsc197_promoter_p_RM_14_17_12 |
 |
 |
9 |
1.0 |
1.93E-04 |
SEMA4A,
PFDN6,
RELB,
HSPA4 |
chaperone-mediated protein complex assembly [BP],
T-helper 1 cell differentiation [BP] |
| CG_ffipsc197_promoter_p_RM_12_232_7 |
 |
 |
4 |
0.8 |
3.34E-04 |
GNAI2 |
negative regulation of synaptic transmission [BP] |
| CG_ffipsc197_promoter_p_RM_12_181_3 |
 |
 |
3 |
0.6 |
2.20E-04 |
OGG1,
SGPL1 |
8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [MF],
oxidized purine nucleobase lesion DNA N-glycosylase activity [MF],
sphinganine-1-phosphate aldolase activity [MF] |
| CG_ffipsc197_promoter_p_RM_14_35_5 |
 |
 |
4 |
0.6 |
3.04E-04 |
LSM11 |
U7 snRNA binding [MF] |
| CG_ffipsc197_promoter_p_RM_12_126_16 |
 |
 |
2 |
0.4 |
3.52E-04 |
ZBTB1,
POLK,
SSNA1,
FOXJ2,
MMP2,
SOD1,
DNAJB6,
ERI1,
TLE4,
ANP32B,
FOXF2,
GLRX5,
GTF2I,
MTAP,
CXADR |
RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity [MF],
nucleus [CC] |
| CG_ffipsc197_promoter_p_RM_12_64_7 |
 |
 |
6 |
0.8 |
3.14E-04 |
PHRF1 |
transcription from RNA polymerase II promoter [BP] |
| CG_ffipsc197_promoter_p_RM_12_151_4 |
 |
 |
5 |
0.8 |
4.46E-04 |
VIL1,
ARF6,
ADHFE1,
PINK1 |
cytoplasmic actin-based contraction involved in cell motility [BP],
lysophosphatidic acid binding [MF],
C3HC4-type RING finger domain binding [MF],
filopodium [CC],
hydroxyacid-oxoacid transhydrogenase activity [MF],
positive regulation of actin filament polymerization [BP],
regulation of protein complex assembly [BP] |
| CG_ffipsc197_promoter_p_RM_12_245_8 |
 |
 |
5 |
0.6 |
2.44E-04 |
NASP,
HSPA4,
SFT2D3,
FAN1,
SERP2,
DYRK2,
STUB1 |
ubiquitin binding [MF],
Hsp90 protein binding [MF],
chaperone-mediated protein complex assembly [BP],
protein transport [BP] |
| CG_ffipsc197_promoter_p_RM_12_172_7 |
 |
 |
5 |
1.0 |
1.68E-04 |
GPT2,
FZD7,
SOX11,
EGR1,
MAP2K1,
PKD2,
MAP2K3,
GPR124,
FZD9,
HES1,
MARC2,
SGPL1 |
pyridoxal phosphate binding [MF],
oligodendrocyte differentiation [BP],
vasculature development [BP],
kidney development [BP],
placenta blood vessel development [BP],
central nervous system development [BP],
S-shaped body morphogenesis [BP],
negative regulation of glial cell proliferation [BP],
MAP kinase kinase activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_45_8 |
 |
 |
4 |
0.8 |
1.71E-04 |
FZR1,
TANC1,
SESN2,
PSMD14,
DBH |
visual learning [BP],
dendritic spine maintenance [BP],
cell cycle arrest [BP],
homoiothermy [BP],
positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle [BP],
chromaffin granule lumen [CC],
anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process [BP],
dopamine beta-monooxygenase activity [MF],
negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle [BP],
regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle [BP],
proteasome regulatory particle, lid subcomplex [CC] |
| CG_ffipsc197_promoter_p_RM_12_149_10 |
 |
 |
5 |
1.0 |
3.69E-04 |
LYN,
PSAT1 |
alpha2-beta1 integrin complex [CC],
positive regulation of dendritic cell apoptotic process [BP],
negative regulation of mast cell proliferation [BP],
positive regulation of oligodendrocyte progenitor proliferation [BP],
O-phospho-L-serine:2-oxoglutarate aminotransferase activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_128_3 |
 |
 |
2 |
0.4 |
2.48E-04 |
GATA3,
PRDX5,
FUK,
TGFBR1 |
thymus development [BP],
negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation [BP],
negative regulation of cell proliferation involved in mesonephros development [BP],
pharyngeal system development [BP],
fucokinase activity [MF],
regulation of histone H3-K27 methylation [BP],
regulation of apoptosis involved in tissue homeostasis [BP],
parathyroid gland development [BP],
peroxynitrite reductase activity [MF],
negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation [BP] |
| CG_ffipsc197_promoter_p_RM_12_276_6 |
 |
 |
2 |
0.4 |
4.20E-04 |
CORO1A,
EEF2K |
elongation factor-2 kinase activity [MF],
negative regulation of actin nucleation [BP] |
| CG_ffipsc197_promoter_p_RM_12_39_8 |
 |
 |
4 |
0.8 |
3.46E-04 |
NR2E1,
MDK |
behavioral fear response [BP],
dentate gyrus development [BP] |
| CG_ffipsc197_promoter_p_RM_12_168_3 |
 |
 |
4 |
0.8 |
2.25E-04 |
ZNF346,
RPS9,
NOL11 |
nucleolus [CC] |
| CG_ffipsc197_promoter_p_RM_12_251_2 |
 |
 |
4 |
0.6 |
2.66E-04 |
CYTH4,
TPM1,
VEGFA |
positive regulation of heart rate by epinephrine [BP],
regulation of cell adhesion [BP],
basophil chemotaxis [BP] |
| CG_ffipsc197_promoter_p_RM_12_130_7 |
 |
 |
4 |
0.6 |
2.80E-04 |
ACSF3 |
malonyl-CoA synthetase activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_274_6 |
 |
 |
2 |
0.4 |
4.79E-04 |
FPGS,
PPP1R8,
AHCYL1 |
ribonuclease E activity [MF],
tetrahydrofolylpolyglutamate synthase activity [MF],
one-carbon metabolic process [BP] |
| CG_ffipsc197_promoter_p_RM_12_147_4 |
 |
 |
5 |
0.8 |
2.24E-04 |
SPHK1,
ADARB1,
GEN1,
MGMT,
ZBED4 |
sphingolipid biosynthetic process [BP],
methylated-DNA-[protein]-cysteine S-methyltransferase activity [MF],
sphingoid catabolic process [BP],
metal ion binding [MF] |
| CG_ffipsc197_promoter_p_RM_12_7_2 |
 |
 |
3 |
0.6 |
3.60E-04 |
HELT,
GIPR,
RNF5,
ACER2 |
gastric inhibitory peptide receptor activity [MF],
negative regulation of protein glycosylation in Golgi [BP],
GABAergic neuron differentiation in basal ganglia [BP],
ER-associated misfolded protein catabolic process [BP] |
| CG_ffipsc197_promoter_p_RM_12_227_7 |
 |
 |
3 |
0.6 |
2.04E-04 |
MGA,
NOS3,
ONECUT2,
PRPF31,
EPN1,
ESRP1,
ID1,
TAF4B,
SMARCA4,
EFCAB13,
NDUFAF3,
CDKN1B,
ALDH1B1,
TULP3,
ZMIZ1,
PRPF6,
ZNF282,
UHRF1,
ZNF74,
ZNF397,
ZNF141 |
transcription, DNA-dependent [BP],
assembly of spliceosomal tri-snRNP [BP],
transcription from RNA polymerase II promoter [BP],
U4/U6 x U5 tri-snRNP complex [CC],
nucleus [CC] |
| CG_ffipsc197_promoter_p_RM_12_91_8 |
 |
 |
4 |
0.6 |
2.85E-04 |
ELAC1,
BMPR1A |
tRNA 3'-trailer cleavage [BP],
paraxial mesoderm structural organization [BP],
neural plate mediolateral regionalization [BP] |
| CG_ffipsc197_promoter_p_RM_14_30_6 |
 |
 |
4 |
0.8 |
2.78E-04 |
TNFRSF14,
XRCC5,
CD40,
TRIM28 |
enzyme binding [MF],
ubiquitin protein ligase binding [MF] |
| CG_ffipsc197_promoter_p_RM_12_201_7 |
 |
 |
3 |
0.6 |
3.60E-04 |
GFER,
GLRX5 |
protein disulfide oxidoreductase activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_288_10 |
 |
 |
7 |
1.0 |
2.97E-04 |
SLC25A37,
DLD,
NFKB1 |
negative regulation of interleukin-12 biosynthetic process [BP],
dihydrolipoyl dehydrogenase activity [MF],
mitochondrial iron ion transport [BP] |
| CG_ffipsc197_promoter_p_RM_12_140_11 |
 |
 |
2 |
0.4 |
1.14E-04 |
HMGA1,
APLF |
DNA-(apurinic or apyrimidinic site) lyase activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_70_5 |
 |
 |
4 |
0.8 |
2.47E-04 |
PPCS |
phosphopantothenate--cysteine ligase activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_186_5 |
 |
 |
3 |
0.6 |
4.78E-04 |
ACVR2A,
ACVR2B,
QSOX1,
MOCS3 |
activin binding [MF],
URM1 activating enzyme activity [MF],
activin-activated receptor activity [MF],
receptor signaling protein serine/threonine kinase activity [MF],
positive regulation of bone mineralization [BP],
transforming growth factor beta-activated receptor activity [MF],
enzyme active site formation via L-cysteine persulfide [BP],
inhibin binding [MF],
positive regulation of activin receptor signaling pathway [BP],
transmembrane receptor protein serine/threonine kinase activity [MF],
gastrulation with mouth forming second [BP],
flavin-linked sulfhydryl oxidase activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_255_9 |
 |
 |
6 |
0.8 |
1.97E-04 |
MPP5,
RIPK1,
HNRNPM,
LYN,
ADIPOQ,
TRIM28 |
protein domain specific binding [MF],
protein autophosphorylation [BP],
negative regulation of ERK1 and ERK2 cascade [BP],
positive regulation of interleukin-8 production [BP] |
| CG_ffipsc197_promoter_p_RM_12_267_6 |
 |
 |
5 |
1.0 |
2.87E-04 |
NDOR1,
DEPTOR,
VPS18,
VPS16,
NDUFV1,
TSC2,
PPCS,
COASY |
negative regulation of cell size [BP],
coenzyme A biosynthetic process [BP],
HOPS complex [CC],
FMN binding [MF],
pantothenate metabolic process [BP] |
| CG_ffipsc197_promoter_p_RM_14_33_3 |
 |
 |
5 |
0.8 |
3.20E-04 |
NOG,
ID2,
HOXC4,
STOX2,
EP300,
FZD2 |
neuron projection membrane [CC],
embryo development [BP],
negative regulation of osteoblast differentiation [BP],
embryonic organ morphogenesis [BP],
heart development [BP] |
| CG_ffipsc197_promoter_p_RM_12_221_6 |
 |
 |
3 |
0.6 |
2.54E-04 |
HCN2,
KCNK2,
KCNQ4 |
voltage-gated potassium channel complex [CC],
potassium channel activity [MF],
voltage-gated potassium channel activity [MF] |
| CG_ffipsc197_promoter_p_RM_14_5_11 |
 |
 |
13 |
1.0 |
5.18E-04 |
YY1,
FOXP4,
AFTPH,
RCOR1,
SLC30A5,
AANAT,
KLHDC2,
FZD1,
COASY,
ZBTB10,
SOX11,
ZIC2,
SLIT2,
CAMTA1,
MVP,
POU3F2,
SIRT1,
GREM1,
NR4A3,
SMG7,
CASC3,
FPGS,
EP300,
PKNOX2,
URI1,
YBX1,
ARID1A,
ERCC6L2,
ATP6V0A1,
PDE1B,
IGHMBP2,
SMARCA4,
MMP2,
ZNF292,
RNF17 |
npBAF complex [CC],
regulation of androgen receptor signaling pathway [BP],
regulation of sequence-specific DNA binding transcription factor activity [BP],
transcription coactivator activity [MF],
hard palate development [BP],
brain development [BP],
RNA polymerase II transcription coactivator activity [MF],
bone trabecula formation [BP],
positive regulation by host of viral transcription [BP],
negative regulation of monocyte chemotaxis [BP],
p53 binding [MF],
negative regulation of transcription, DNA-dependent [BP],
androgen receptor signaling pathway [BP],
positive regulation of sequence-specific DNA binding transcription factor activity [BP],
N-terminal protein amino acid acetylation [BP],
nBAF complex [CC],
negative regulation of gene expression [BP],
negative regulation of leukocyte chemotaxis [BP],
nucleus [CC] |
| CG_ffipsc197_promoter_p_RM_12_285_11 |
 |
 |
5 |
1.0 |
2.78E-04 |
ACADS,
ADIPOQ,
RAC1,
CPT1C |
ruffle assembly [BP],
fatty acid beta-oxidation [BP] |
| CG_ffipsc197_promoter_p_RM_12_148_9 |
 |
 |
4 |
0.8 |
3.26E-04 |
SMARCB1,
ZNF526,
HLX,
ID2,
PPARD,
ZIC2,
ZNF276,
HES3,
TGIF1,
EHMT1 |
transcription, DNA-dependent [BP],
adipose tissue development [BP],
embryo development [BP],
embryonic digestive tract morphogenesis [BP] |
| CG_ffipsc197_promoter_p_RM_16_2_11 |
 |
 |
11 |
1.0 |
4.78E-04 |
BMPR2,
VIL1 |
positive regulation of epithelial cell migration [BP] |
| CG_ffipsc197_promoter_p_RM_12_272_5 |
 |
 |
2 |
0.4 |
3.77E-04 |
GSTZ1,
TRAF4,
DAG1,
CARM1,
MAP3K10 |
histone methyltransferase activity (H3-R17 specific) [MF],
histone H3-R17 methylation [BP],
positive regulation of JNK cascade [BP],
nerve maturation [BP],
maleylacetoacetate isomerase activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_110_10 |
 |
 |
4 |
0.8 |
2.73E-04 |
SENP6,
TBR1,
PIAS1,
ZIC2,
NR2E1,
WNT3A |
axonogenesis [BP],
amygdala development [BP],
protein sumoylation [BP],
brain development [BP],
hippocampus development [BP],
forebrain generation of neurons [BP],
positive regulation of mesodermal cell fate specification [BP],
positive regulation of canonical Wnt receptor signaling pathway involved in controlling type B pancreatic cell proliferation [BP],
regulation of neuron projection development [BP] |
| CG_ffipsc197_promoter_p_RM_14_42_2 |
 |
 |
4 |
0.4 |
6.14E-04 |
COASY,
ZMIZ1 |
vitellogenesis [BP],
dephospho-CoA kinase activity [MF],
pantetheine-phosphate adenylyltransferase activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_270_9 |
 |
 |
3 |
0.6 |
2.51E-04 |
ZBED4,
STUB1,
PKN3,
ID1,
BMPR2,
PML,
RNF20,
NPR1 |
negative regulation of cell growth [BP],
protein dimerization activity [MF],
ubiquitin protein ligase binding [MF],
transmembrane receptor protein serine/threonine kinase signaling pathway [BP],
ubiquitin conjugating enzyme complex [CC],
epithelial cell migration [BP],
lymphatic endothelial cell differentiation [BP] |
| CG_ffipsc197_promoter_p_RM_12_222_5 |
 |
 |
4 |
0.8 |
3.51E-04 |
FAM20C,
NUDC,
PCNT,
LZTS2 |
microtubule [CC],
odontoblast differentiation [BP],
dentinogenesis [BP],
mitotic cell cycle [BP],
neural precursor cell proliferation [BP],
osteoclast maturation [BP] |
| CG_ffipsc197_promoter_p_RM_12_248_12 |
 |
 |
5 |
0.8 |
3.57E-04 |
GMNN,
ID4,
HINFP,
ZNF274,
PCBD2 |
transcription corepressor activity [MF],
positive regulation of gene expression [BP],
positive regulation of transcription, DNA-dependent [BP] |
| CG_ffipsc197_promoter_p_RM_12_131_4 |
 |
 |
3 |
0.6 |
3.99E-04 |
PDXK,
NRG3 |
lithium ion binding [MF],
pyridoxal phosphate biosynthetic process [BP],
pyridoxal 5'-phosphate salvage [BP],
receptor tyrosine kinase binding [MF],
pyridoxal kinase activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_21_8 |
 |
 |
4 |
0.8 |
2.07E-04 |
RBPJL,
IRF9,
CREB1,
HOXD3,
ETS2,
PPARD,
PAX2,
MYCN |
negative regulation of reactive oxygen species metabolic process [BP],
positive regulation of transcription, DNA-dependent [BP],
sequence-specific DNA binding [MF],
sequence-specific DNA binding transcription factor activity [MF],
RNA polymerase II regulatory region sequence-specific DNA binding [MF],
regulatory region DNA binding [MF],
positive regulation of gene expression [BP] |
| CG_ffipsc197_promoter_p_RM_12_32_6 |
 |
 |
4 |
0.8 |
5.35E-04 |
BMPR2,
MAP2K5,
NR2F2,
NANOS1 |
lymphatic endothelial cell differentiation [BP],
epithelial cell migration [BP],
positive regulation of epithelial cell proliferation [BP],
negative regulation of endothelial cell migration [BP] |
| CG_ffipsc197_promoter_p_RM_12_74_3 |
 |
 |
5 |
1.0 |
2.28E-04 |
FBXL15,
ACVRL1 |
positive regulation of BMP signaling pathway [BP] |
| CG_ffipsc197_promoter_p_RM_14_11_7 |
 |
 |
3 |
0.6 |
2.13E-04 |
MTM1,
HES1 |
N-box binding [MF],
phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [MF],
negative regulation of forebrain neuron differentiation [BP],
negative regulation of stomach neuroendocrine cell differentiation [BP],
negative regulation of pancreatic A cell differentiation [BP],
lateral inhibition [BP],
negative regulation of auditory receptor cell differentiation [BP],
renal interstitial cell development [BP],
positive regulation of mitotic cell cycle, embryonic [BP] |
| CG_ffipsc197_promoter_p_RM_14_37_5 |
 |
 |
5 |
0.8 |
2.58E-04 |
GRIN1,
CYP1A2 |
oxidative deethylation [BP],
toxin biosynthetic process [BP],
propylene metabolic process [BP] |
| CG_ffipsc197_promoter_p_RM_12_154_8 |
 |
 |
6 |
1.0 |
2.85E-04 |
NR2E1,
MAPK8IP3,
FOXF1,
LRP5,
PGM5 |
amygdala development [BP],
lung alveolus development [BP],
positive regulation of mesenchymal cell proliferation [BP],
detection of wounding [BP],
retina morphogenesis in camera-type eye [BP],
mesenchyme migration [BP],
right lung morphogenesis [BP],
retina development in camera-type eye [BP],
spot adherens junction [CC],
embryonic ectodermal digestive tract morphogenesis [BP],
branching involved in open tracheal system development [BP],
lung morphogenesis [BP] |
| CG_ffipsc197_promoter_p_RM_12_34_7 |
 |
 |
6 |
1.0 |
4.49E-04 |
GNPAT,
GREM1,
SPRED3,
GPS1 |
inactivation of MAPK activity [BP],
regulation of epithelial to mesenchymal transition [BP],
glycerone-phosphate O-acyltransferase activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_160_7 |
 |
 |
2 |
0.4 |
4.50E-04 |
PSME1,
OAZ1,
RNF5 |
regulation of cellular amino acid metabolic process [BP],
ER-associated misfolded protein catabolic process [BP] |
| CG_ffipsc197_promoter_p_RM_12_76_4 |
 |
 |
4 |
0.6 |
2.27E-04 |
LMNA |
sterol regulatory element binding protein import into nucleus [BP] |
| CG_ffipsc197_promoter_p_RM_16_10_1 |
 |
 |
3 |
0.6 |
2.16E-04 |
PVRL2,
DTX1,
SLC22A18,
NOD2,
CD4 |
macrophage inflammatory protein-1 alpha production [BP],
detection of muramyl dipeptide [BP],
activation of MAPK activity involved in innate immune response [BP],
defense response to bacterium [BP],
coreceptor activity [MF],
cell surface [CC],
regulation of immune response [BP],
negative regulation of interleukin-18 production [BP],
positive regulation of dendritic cell cytokine production [BP],
entry into host cell [BP],
regulation of T cell activation [BP],
virion attachment, binding of host cell surface coreceptor [BP],
regulation of Notch signaling pathway [BP],
positive regulation of immunoglobulin mediated immune response [BP],
sperm mitochondrion organization [BP],
positive regulation of peptidyl-tyrosine phosphorylation [BP],
Notch signaling pathway [BP],
positive regulation of prostaglandin-E synthase activity [BP],
susceptibility to T cell mediated cytotoxicity [BP],
protein palmitoleylation [BP],
induction by virus of host cell-cell fusion [BP],
enzyme binding [MF],
ubiquitin protein ligase binding [MF],
positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria [BP],
microglial cell activation involved in immune response [BP],
pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response [BP],
innate immune response [BP],
muramyl dipeptide binding [MF] |
| CG_ffipsc197_promoter_p_RM_12_5_6 |
 |
 |
4 |
0.8 |
3.56E-04 |
KIF26A,
YTHDC2,
ARF1 |
ATP-dependent helicase activity [MF],
antigen processing and presentation of exogenous peptide antigen via MHC class II [BP],
regulation of cell growth by extracellular stimulus [BP] |
| CG_ffipsc197_promoter_p_RM_12_235_8 |
 |
 |
2 |
0.4 |
1.77E-04 |
HEY2,
NPY5R,
HES1 |
vascular smooth muscle cell development [BP],
ascending aorta morphogenesis [BP],
cardiac left ventricle morphogenesis [BP],
labyrinthine layer blood vessel development [BP],
outflow tract morphogenesis [BP],
regulation of auditory receptor cell differentiation [BP] |
| CG_ffipsc197_promoter_p_RM_12_150_2 |
 |
 |
5 |
0.8 |
1.08E-04 |
COL13A1,
DCC,
NEFH,
TPGS1 |
collagen type XIII [CC],
axon [CC] |
| CG_ffipsc197_promoter_p_RM_12_162_12 |
 |
 |
6 |
1.0 |
4.16E-04 |
ADORA2B,
PCYOX1 |
chloride-transporting ATPase activity [MF],
prenylcysteine oxidase activity [MF],
positive regulation of chronic inflammatory response to non-antigenic stimulus [BP] |
| CG_ffipsc197_promoter_p_RM_12_240_6 |
 |
 |
4 |
0.8 |
1.65E-04 |
BAMBI,
SHOC2,
WNT5B |
Wnt receptor signaling pathway [BP],
protein phosphatase regulator activity [MF],
frizzled binding [MF] |
| CG_ffipsc197_promoter_p_RM_12_46_10 |
 |
 |
2 |
0.4 |
2.23E-04 |
IMPACT |
negative regulation of protein phosphorylation [BP] |
| CG_ffipsc197_promoter_p_RM_14_40_3 |
 |
 |
5 |
0.8 |
3.01E-04 |
FOS,
PSMD11,
TCERG1,
E2F5,
MCM5,
NUP214,
NFKB1,
STIP1,
PAPOLG,
TPX2 |
negative regulation of interleukin-12 biosynthetic process [BP],
nucleoplasm [CC],
protein complex [CC],
nucleus [CC] |
| CG_ffipsc197_promoter_p_RM_14_36_4 |
 |
 |
4 |
0.6 |
2.11E-04 |
IL6R |
ciliary neurotrophic factor binding [MF] |
| CG_ffipsc197_promoter_p_RM_12_119_3 |
 |
 |
3 |
0.6 |
2.00E-04 |
XPOT |
tRNA export from nucleus [BP] |
| CG_ffipsc197_promoter_p_RM_12_156_5 |
 |
 |
4 |
0.8 |
2.94E-04 |
UHRF1,
UBR2,
CEBPB |
cellular response to amino acid stimulus [BP],
euchromatin [CC],
histone ubiquitination [BP],
chromatin [CC],
nuclear chromatin [CC] |
| CG_ffipsc197_promoter_p_RM_12_53_10 |
 |
 |
4 |
0.8 |
2.47E-04 |
SPHK1,
LEPROT |
sphingoid catabolic process [BP],
negative regulation of growth hormone receptor signaling pathway [BP] |
| CG_ffipsc197_promoter_p_RM_12_266_10 |
 |
 |
5 |
0.8 |
3.23E-04 |
ALDH1A3,
TRIB1,
HSPB1,
NR2F2 |
protein kinase inhibitor activity [MF],
radial pattern formation [BP],
negative regulation of protein kinase activity [BP],
nucleus accumbens development [BP] |
| CG_ffipsc197_promoter_p_RM_12_233_5 |
 |
 |
7 |
1.0 |
3.73E-04 |
MIB1,
RXRA,
LCK,
PROX1,
BCR,
TRIM24 |
positive regulation of endocytosis [BP],
ventricular cardiac muscle cell differentiation [BP],
ligand-dependent nuclear receptor binding [MF],
protein kinase activity [MF],
kinase activity [MF],
cellular zinc ion homeostasis [BP] |
| CG_ffipsc197_promoter_p_RM_12_97_12 |
 |
 |
7 |
1.0 |
2.66E-04 |
EXTL3,
HS3ST3B1,
CD38 |
B cell receptor signaling pathway [BP],
heparan sulfate proteoglycan biosynthetic process [BP] |
| CG_ffipsc197_promoter_p_RM_12_13_5 |
 |
 |
4 |
0.8 |
2.71E-04 |
SQLE,
DUT |
squalene monooxygenase activity [MF],
dUTP diphosphatase activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_66_17 |
 |
 |
4 |
0.8 |
5.02E-04 |
PGS1,
AGPAT6 |
diacylglycerol metabolic process [BP] |
| CG_ffipsc197_promoter_p_RM_12_92_4 |
 |
 |
4 |
0.4 |
2.24E-04 |
AGRN |
positive regulation of synaptic growth at neuromuscular junction [BP] |
| CG_ffipsc197_promoter_p_RM_16_4_2 |
 |
 |
3 |
0.6 |
4.06E-04 |
GRIN1 |
synaptic cleft [CC],
propylene metabolic process [BP] |
| CG_ffipsc197_promoter_p_RM_12_132_4 |
 |
 |
3 |
0.6 |
2.16E-04 |
CTHRC1,
PBX1,
TGFBR1 |
Wnt receptor signaling pathway, planar cell polarity pathway [BP],
thymus development [BP] |
| CG_ffipsc197_promoter_p_RM_14_41_3 |
 |
 |
5 |
0.6 |
1.77E-04 |
FOXD3,
HMGB3 |
DNA binding, bending [MF] |
| CG_ffipsc197_promoter_p_RM_12_198_10 |
 |
 |
3 |
0.6 |
3.45E-04 |
CD4 |
protein palmitoleylation [BP],
induction by virus of host cell-cell fusion [BP] |
| CG_ffipsc197_promoter_p_RM_12_29_4 |
 |
 |
2 |
0.4 |
3.89E-04 |
ING2 |
regulation of response to DNA damage stimulus [BP] |
| CG_ffipsc197_promoter_p_RM_12_142_6 |
 |
 |
2 |
0.4 |
2.34E-04 |
POU3F2 |
neurohypophysis development [BP] |
| CG_ffipsc197_promoter_p_RM_12_204_8 |
 |
 |
5 |
0.8 |
1.91E-04 |
MAN2B2,
ABCG8,
MAN2A1,
HTR6,
PTK2B,
PTPRM,
TGFB2 |
mannose metabolic process [BP],
response to drug [BP],
positive regulation of stress-activated MAPK cascade [BP],
alpha-mannosidase activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_11_7 |
 |
 |
4 |
0.8 |
3.79E-04 |
AGAP1,
RAB40C,
RAB10,
DOCK5,
DOCK2 |
small GTPase mediated signal transduction [BP] |
| CG_ffipsc197_promoter_p_RM_12_40_3 |
 |
 |
4 |
0.8 |
2.06E-04 |
PROX1 |
positive regulation of forebrain neuron differentiation [BP],
hepatocyte cell migration [BP],
DBD domain binding [MF],
positive regulation of G1/S transition checkpoint [BP] |
| CG_ffipsc197_promoter_p_RM_14_47_3 |
 |
 |
3 |
0.6 |
1.96E-04 |
PRKCD,
LRP5,
ZHX2 |
embryonic camera-type eye morphogenesis [BP],
response to glucose stimulus [BP],
somatic stem cell maintenance [BP] |
| CG_ffipsc197_promoter_p_RM_12_192_5 |
 |
 |
4 |
0.8 |
1.80E-04 |
E2F5,
POU4F2,
MYB,
ZIC3,
FOXQ1 |
determination of left/right asymmetry in nervous system [BP],
positive regulation of transcription from RNA polymerase II promoter [BP] |
| CG_ffipsc197_promoter_p_RM_12_152_8 |
 |
 |
4 |
0.6 |
3.03E-04 |
SOX2 |
detection of mechanical stimulus involved in equilibrioception [BP] |
| CG_ffipsc197_promoter_p_RM_14_16_5 |
 |
 |
6 |
0.6 |
2.98E-04 |
MARCH9,
SLC48A1,
ENPP1,
VPS18 |
inorganic diphosphate transport [BP],
lysosomal membrane [CC] |
| CG_ffipsc197_promoter_p_RM_12_209_4 |
 |
 |
4 |
0.8 |
3.05E-04 |
TALDO1,
FOXF1 |
embryonic ectodermal digestive tract morphogenesis [BP],
detection of wounding [BP],
mesenchyme migration [BP],
sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [MF],
branching involved in open tracheal system development [BP],
right lung morphogenesis [BP] |
| CG_ffipsc197_promoter_p_RM_12_269_6 |
 |
 |
6 |
1.0 |
1.89E-04 |
EYA4,
MBD3L1,
ZBTB7B,
GTF2IRD2B |
regulation of transcription, DNA-dependent [BP] |
| CG_ffipsc197_promoter_p_RM_16_8_1 |
 |
 |
3 |
0.4 |
6.66E-04 |
COASY,
ZMIZ1 |
vitellogenesis [BP],
dephospho-CoA kinase activity [MF],
pantetheine-phosphate adenylyltransferase activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_103_2 |
 |
 |
2 |
0.4 |
6.57E-05 |
GCC2,
CLYBL |
late endosome to Golgi transport [BP],
citrate (pro-3S)-lyase activity [MF],
recycling endosome to Golgi transport [BP] |
| CG_ffipsc197_promoter_p_RM_12_144_4 |
 |
 |
6 |
0.8 |
3.60E-04 |
ISL1,
ZIC2,
SMAD4,
SOX2 |
neuron fate commitment [BP],
chromatin binding [MF],
retinal ganglion cell axon guidance [BP],
transcription regulatory region sequence-specific DNA binding [MF] |
| CG_ffipsc197_promoter_p_RM_12_105_8 |
 |
 |
4 |
0.8 |
3.47E-04 |
DPYSL2,
RAC1,
COMMD1,
SSH3,
RBX1,
HTRA2,
NR2E1,
POU3F2 |
regulation of lamellipodium assembly [BP],
cerebral cortex radially oriented cell migration [BP],
olfactory bulb development [BP],
Cul2-RING ubiquitin ligase complex [CC],
forebrain development [BP] |
| CG_ffipsc197_promoter_p_RM_12_197_13 |
 |
 |
6 |
1.0 |
4.79E-04 |
MTAP,
CHAT,
AMD1,
ENOPH1 |
L-methionine salvage from methylthioadenosine [BP],
rhythmic behavior [BP],
polyamine metabolic process [BP] |
| CG_ffipsc197_promoter_p_RM_12_281_6 |
 |
 |
4 |
0.8 |
3.89E-04 |
PIKFYVE |
myelin assembly [BP] |
| CG_ffipsc197_promoter_p_RM_12_44_7 |
 |
 |
4 |
0.8 |
1.84E-04 |
STK4,
TEAD1 |
hippo signaling cascade [BP] |
| CG_ffipsc197_promoter_p_RM_12_206_9 |
 |
 |
7 |
1.0 |
1.58E-04 |
MAPK8IP1 |
dentate gyrus mossy fiber [CC] |
| CG_ffipsc197_promoter_p_RM_12_84_4 |
 |
 |
4 |
0.8 |
3.88E-04 |
ACSF3,
AATF,
DKK1,
LYN |
malonate catabolic process [BP],
positive regulation of oligodendrocyte progenitor proliferation [BP],
positive regulation of dendritic cell apoptotic process [BP],
negative regulation of mast cell proliferation [BP],
negative regulation of superoxide anion generation [BP],
negative regulation of canonical Wnt receptor signaling pathway involved in cardiac muscle cell fate commitment [BP] |
| CG_ffipsc197_promoter_p_RM_12_247_11 |
 |
 |
7 |
0.8 |
3.02E-04 |
SCUBE3,
NLGN1,
ZFPM2,
SOX11,
JUNB,
TLE4,
CHRNB1,
PVRL2,
CACNA1H,
NSD1,
EDNRA,
MYB,
P2RX7,
WNT3A |
osteoblast differentiation [BP],
cell surface [CC],
positive regulation of prostaglandin secretion [BP],
postsynaptic membrane organization [BP],
transcription cofactor activity [MF],
embryonic organ development [BP],
in utero embryonic development [BP],
RNA polymerase II transcription coactivator activity [MF],
transcription corepressor activity [MF],
scaffold protein binding [MF],
cation transport [BP],
positive regulation of T cell mediated cytotoxicity [BP] |
| CG_ffipsc197_promoter_p_RM_12_218_8 |
 |
 |
4 |
0.8 |
2.79E-04 |
SALL3,
RBBP4,
GATAD2A |
NuRD complex [CC],
negative regulation of smoothened signaling pathway [BP] |
| CG_ffipsc197_promoter_p_RM_12_54_4 |
 |
 |
5 |
1.0 |
3.58E-04 |
SFTPC,
NLGN1,
PVRL2,
FOXL1,
SLC2A4 |
neurexin clustering [BP],
positive regulation of synaptic vesicle endocytosis [BP],
multivesicular body [CC],
cell adhesion molecule binding [MF],
visceral mesoderm-endoderm interaction involved in midgut development [BP],
amylopectin biosynthetic process [BP],
virion attachment, binding of host cell surface coreceptor [BP],
respiratory gaseous exchange [BP],
cytoskeletal matrix organization at active zone [BP],
positive regulation of synaptic vesicle exocytosis [BP] |
| CG_ffipsc197_promoter_p_RM_12_210_3 |
 |
 |
2 |
0.4 |
2.96E-04 |
TPM1 |
positive regulation of heart rate by epinephrine [BP] |
| CG_ffipsc197_promoter_p_RM_14_20_3 |
 |
 |
4 |
0.6 |
5.67E-04 |
WNT1,
CNTN2 |
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [BP],
positive regulation of adenosine receptor signaling pathway [BP],
canonical Wnt receptor signaling pathway involved in negative regulation of apoptotic process [BP],
regulation of axon diameter [BP],
cerebellum formation [BP],
neuron fate determination [BP],
clustering of voltage-gated potassium channels [BP],
brain segmentation [BP],
ubiquitin-dependent SMAD protein catabolic process [BP],
positive regulation of dermatome development [BP],
central nervous system morphogenesis [BP],
Spemann organizer formation [BP],
midbrain-hindbrain boundary maturation during brain development [BP],
positive regulation of lamellipodium assembly [BP],
fourth ventricle development [BP],
cerebral cortex GABAergic interneuron migration [BP],
establishment of protein localization to juxtaparanode region of axon [BP],
forebrain anterior/posterior pattern specification [BP],
negative regulation of DNA damage checkpoint [BP] |
| CG_ffipsc197_promoter_p_RM_12_33_7 |
 |
 |
5 |
1.0 |
1.84E-04 |
PBX3,
NR2F2,
GM2A |
anterior compartment pattern formation [BP],
radial pattern formation [BP],
sphingolipid activator protein activity [MF],
posterior compartment specification [BP] |
| CG_ffipsc197_promoter_p_RM_12_35_8 |
 |
 |
2 |
0.4 |
1.79E-04 |
MYO6,
HMGCR,
PPWD1,
PPIL2 |
hydroxymethylglutaryl-CoA reductase activity [MF],
hydroxymethylglutaryl-CoA reductase (NADPH) activity [MF],
auditory receptor cell differentiation [BP],
minus-end directed microfilament motor activity [MF],
peptidyl-prolyl cis-trans isomerase activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_101_9 |
 |
 |
4 |
0.8 |
2.81E-04 |
ING1,
L3MBTL1 |
methylated histone residue binding [MF] |
| CG_ffipsc197_promoter_p_RM_12_27_7 |
 |
 |
4 |
0.8 |
3.25E-04 |
NOG,
EGFR,
NR2E1,
RNASE2,
RNASE3 |
negative regulation of astrocyte differentiation [BP],
morphogenesis of an epithelial fold [BP],
cerebral cortex cell migration [BP],
pancreatic ribonuclease activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_19_3 |
 |
 |
3 |
0.6 |
1.53E-04 |
B3GALT4 |
ganglioside galactosyltransferase activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_118_8 |
 |
 |
3 |
0.6 |
3.02E-04 |
PIK3CD,
EGR1 |
T cell differentiation [BP],
mast cell differentiation [BP] |
| CG_ffipsc197_promoter_p_RM_12_37_4 |
 |
 |
5 |
1.0 |
3.70E-04 |
EMG1 |
rRNA (pseudouridine) methyltransferase activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_49_9 |
 |
 |
4 |
0.8 |
3.38E-04 |
CDKN1A,
GATC,
GNAO1 |
regulation of translational fidelity [BP],
mu-type opioid receptor binding [MF],
PCNA-p21 complex [CC],
cyclin-dependent protein kinase activating kinase activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_139_3 |
 |
 |
3 |
0.6 |
2.71E-04 |
SKI,
NUPL1,
DDX20,
SENP2,
FAM20C |
nuclear body [CC],
transcriptional repressor complex [CC],
PML body [CC],
dentinogenesis [BP],
nuclear pore [CC],
osteoclast maturation [BP] |
| CG_ffipsc197_promoter_p_RM_14_9_5 |
 |
 |
4 |
0.6 |
1.50E-04 |
TCAP,
PAOX,
ACTN3 |
structural constituent of muscle [MF],
N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [MF],
N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [MF],
muscle filament sliding [BP],
spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity [MF],
positive regulation of spermidine biosynthetic process [BP],
N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_214_8 |
 |
 |
3 |
0.6 |
2.33E-04 |
FSTL3,
NF1,
FAM213A |
negative regulation of osteoclast differentiation [BP],
regulation of osteoclast differentiation [BP] |
| CG_ffipsc197_promoter_p_RM_12_223_7 |
 |
 |
5 |
1.0 |
2.81E-04 |
HOXC4,
MYO1B,
ATG10,
BMPR1A,
GALR1,
GATA4,
GRM7,
ESPN |
brush border [CC],
SMAD binding [MF],
negative regulation of adenylate cyclase activity [BP],
negative regulation of cAMP biosynthetic process [BP],
lung lobe formation [BP],
endoderm development [BP],
adenylate cyclase inhibitor activity [MF],
anterior/posterior pattern specification [BP],
neural plate mediolateral regionalization [BP],
autophagy in response to ER overload [BP],
paraxial mesoderm structural organization [BP],
endocardial cushion development [BP] |
| CG_ffipsc197_promoter_p_RM_12_124_9 |
 |
 |
2 |
0.4 |
2.84E-04 |
AP2A2,
PACS1 |
regulation of defense response to virus by virus [BP] |
| CG_ffipsc197_promoter_p_RM_12_10_5 |
 |
 |
2 |
0.4 |
2.01E-04 |
EPB41,
ARF6 |
cortical actin cytoskeleton organization [BP] |
| CG_ffipsc197_promoter_p_RM_12_219_8 |
 |
 |
7 |
1.0 |
2.68E-04 |
FZD7 |
negative regulation of ectodermal cell fate specification [BP] |
| CG_ffipsc197_promoter_p_RM_12_56_5 |
 |
 |
4 |
0.8 |
1.75E-04 |
ADPRHL2,
HLX,
PROX1 |
positive regulation of organ growth [BP],
positive regulation of G1/S transition checkpoint [BP],
positive regulation of forebrain neuron differentiation [BP],
DBD domain binding [MF],
hepatocyte cell migration [BP],
poly(ADP-ribose) glycohydrolase activity [MF] |
| CG_ffipsc197_promoter_p_RM_14_29_2 |
 |
 |
3 |
0.6 |
2.83E-04 |
NR2F2 |
radial pattern formation [BP] |
| CG_ffipsc197_promoter_p_RM_12_96_7 |
 |
 |
7 |
1.0 |
3.53E-04 |
UNCX,
SLC6A1 |
gamma-aminobutyric acid import [BP],
olfactory bulb interneuron differentiation [BP] |
| CG_ffipsc197_promoter_p_RM_16_6_1 |
 |
 |
2 |
0.4 |
6.33E-04 |
PCDHA12,
PCDHA13,
PCDHA10 |
homophilic cell adhesion [BP],
calcium ion binding [MF],
cell adhesion [BP] |
| CG_ffipsc197_promoter_p_RM_12_31_6 |
 |
 |
4 |
0.8 |
3.59E-04 |
CMPK1,
UCK2,
THBS1,
CCND1 |
UMP biosynthetic process [BP],
response to magnesium ion [BP],
nucleoside kinase activity [MF],
uridine kinase activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_261_5 |
 |
 |
5 |
1.0 |
2.05E-04 |
AK4 |
tetracycline metabolic process [BP],
carbon tetrachloride metabolic process [BP] |
| CG_ffipsc197_promoter_p_RM_12_243_13 |
 |
 |
5 |
0.8 |
4.07E-04 |
FZD2,
DAO,
HINFP,
HNRNPAB |
D-alanine catabolic process [BP],
D-serine catabolic process [BP],
positive regulation of gene expression [BP],
positive regulation of transcription, DNA-dependent [BP] |
| CG_ffipsc197_promoter_p_RM_12_80_5 |
 |
 |
4 |
0.6 |
3.45E-04 |
PPP1CB,
NDUFB2,
WWOX,
NDUFV1 |
myosin phosphatase activity [MF],
mitochondrial respiratory chain complex I [CC],
myosin-light-chain-phosphatase activity [MF],
oxidation-reduction process [BP],
mitochondrial electron transport, NADH to ubiquinone [BP],
NADH dehydrogenase (ubiquinone) activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_216_6 |
 |
 |
4 |
0.6 |
2.10E-04 |
SLC2A4,
PANX1,
F2RL1,
MDM2,
FFAR4,
EGR1 |
interleukin-1 beta secretion [BP],
endomembrane system [CC],
cellular response to antibiotic [BP],
hexose transport [BP],
scaffold protein binding [MF],
negative regulation of cytokine secretion [BP],
glucose transport [BP],
cellular response to alkaloid [BP] |
| CG_ffipsc197_promoter_p_RM_14_46_2 |
 |
 |
4 |
0.6 |
2.81E-04 |
FN3K |
fructosamine-3-kinase activity [MF],
fructoselysine metabolic process [BP] |
| CG_ffipsc197_promoter_p_RM_12_14_6 |
 |
 |
3 |
0.6 |
2.34E-04 |
MED25,
FXYD5 |
positive regulation of chromatin binding [BP],
positive regulation of mediator complex assembly [BP],
negative regulation of calcium-dependent cell-cell adhesion [BP] |
| CG_ffipsc197_promoter_p_RM_12_48_10 |
 |
 |
2 |
0.4 |
3.43E-04 |
AEBP1,
PTPRZ1,
ZP1 |
extracellular matrix [CC],
proteinaceous extracellular matrix [CC] |
| CG_ffipsc197_promoter_p_RM_12_47_5 |
 |
 |
4 |
0.6 |
3.33E-04 |
RAB5A,
PPP1R16B |
regulation of filopodium assembly [BP] |
| CG_ffipsc197_promoter_p_RM_16_3_1 |
 |
 |
2 |
0.4 |
2.76E-04 |
ITM2B |
negative regulation of amyloid precursor protein biosynthetic process [BP] |
| CG_ffipsc197_promoter_p_RM_12_194_3 |
 |
 |
2 |
0.4 |
3.89E-04 |
ENOPH1,
MOG,
L3MBTL1 |
SAM domain binding [MF],
acireductone synthase activity [MF],
positive regulation of MyD88-dependent toll-like receptor signaling pathway [BP] |
| CG_ffipsc197_promoter_p_RM_12_120_7 |
 |
 |
4 |
0.8 |
3.47E-04 |
PDZK1,
ARHGAP26 |
scavenger receptor binding [MF],
filopodium assembly [BP] |
| CG_ffipsc197_promoter_p_RM_12_173_7 |
 |
 |
6 |
1.0 |
3.76E-04 |
VWA1,
APLP1 |
basement membrane [CC] |
| CG_ffipsc197_promoter_p_RM_12_284_6 |
 |
 |
4 |
0.8 |
4.16E-04 |
ILK,
SYNM |
costamere [CC] |
| CG_ffipsc197_promoter_p_RM_12_175_4 |
 |
 |
2 |
0.4 |
2.86E-04 |
PRDX5,
MAVS,
HERC5,
CLIC6 |
negative regulation of type I interferon production [BP],
D4 dopamine receptor binding [MF],
D2 dopamine receptor binding [MF],
positive regulation of IP-10 production [BP],
regulation of apoptosis involved in tissue homeostasis [BP],
peroxynitrite reductase activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_113_5 |
 |
 |
5 |
0.8 |
2.34E-04 |
IL10RB |
interleukin-10 receptor activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_258_17 |
 |
 |
5 |
1.0 |
2.42E-04 |
CCNK,
GNAI2,
CAMK4,
GNAS,
MDM2 |
cellular response to estrogen stimulus [BP],
positive regulation of protein export from nucleus [BP],
G-protein beta/gamma-subunit complex binding [MF],
negative regulation of cell cycle arrest [BP],
cAMP biosynthetic process [BP] |
| CG_ffipsc197_promoter_p_RM_12_166_8 |
 |
 |
5 |
1.0 |
3.00E-04 |
MAVS,
SQLE,
GATA4 |
squalene monooxygenase activity [MF],
lung lobe formation [BP],
positive regulation of IP-10 production [BP] |
| CG_ffipsc197_promoter_p_RM_16_5_1 |
 |
 |
1 |
0.2 |
7.13E-04 |
HIST1H2AH,
HIST1H2AC,
HIST1H2BO |
nucleosome assembly [BP],
nucleosome [CC],
protein heterodimerization activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_104_6 |
 |
 |
4 |
0.8 |
7.71E-05 |
PRPF6,
ABCG8 |
negative regulation of intestinal phytosterol absorption [BP],
U4/U6 snRNP [CC],
U4/U6 x U5 tri-snRNP complex [CC],
negative regulation of intestinal cholesterol absorption [BP] |
| CG_ffipsc197_promoter_p_RM_16_9_1 |
 |
 |
9 |
0.8 |
2.56E-04 |
MSL1,
CABP4 |
photoreceptor cell morphogenesis [BP],
MSL complex [CC] |
| CG_ffipsc197_promoter_p_RM_12_9_5 |
 |
 |
4 |
0.6 |
1.75E-04 |
PRDX5,
IVD |
regulation of apoptosis involved in tissue homeostasis [BP],
isovaleryl-CoA dehydrogenase activity [MF],
peroxynitrite reductase activity [MF] |
| CG_ffipsc197_promoter_p_RM_14_45_1 |
 |
 |
2 |
0.4 |
4.55E-04 |
ATP2A2,
LIN28B |
miRNA catabolic process [BP],
relaxation of cardiac muscle [BP],
calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential [MF] |
| CG_ffipsc197_promoter_p_RM_12_137_6 |
 |
 |
2 |
0.4 |
3.69E-04 |
POLR2B,
POLR3E |
DNA-directed RNA polymerase activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_72_7 |
 |
 |
3 |
0.6 |
3.11E-04 |
BCL2L11,
PPP1R1B,
CACNA1C |
visual learning [BP],
caveolar macromolecular signaling complex [CC],
BIM-BCL-2 complex [CC],
BIM-BCL-xl complex [CC],
calcium-mediated signaling using extracellular calcium source [BP] |
| CG_ffipsc197_promoter_p_RM_12_83_5 |
 |
 |
6 |
1.0 |
3.03E-04 |
FZD3,
PROX1,
FZD6,
NTN1 |
neuron projection membrane [CC],
cell proliferation in midbrain [BP],
establishment of planar polarity [BP],
inner ear morphogenesis [BP],
positive regulation of G1/S transition checkpoint [BP],
positive regulation of forebrain neuron differentiation [BP],
Wnt-protein binding [MF],
DBD domain binding [MF],
Wnt-activated receptor activity [MF],
neural tube development [BP],
hepatocyte cell migration [BP],
G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger [BP] |
| CG_ffipsc197_promoter_p_RM_14_19_1 |
 |
 |
2 |
0.4 |
2.47E-04 |
MAPRE1 |
cortical microtubule cytoskeleton [CC] |
| CG_ffipsc197_promoter_p_RM_12_292_6 |
 |
 |
5 |
1.0 |
2.30E-05 |
SPIRE2,
FSD1 |
polar body extrusion after meiotic divisions [BP],
formin-nucleated actin cable assembly [BP],
cleavage furrow [CC] |
| CG_ffipsc197_promoter_p_RM_12_282_3 |
 |
 |
4 |
0.8 |
9.11E-05 |
ZIC2,
RAB25,
POU4F2 |
pseudopodium membrane [CC],
retinal ganglion cell axon guidance [BP] |
| CG_ffipsc197_promoter_p_RM_16_7_5 |
 |
 |
9 |
1.0 |
5.15E-04 |
GREM1,
MMP2,
SLIT2,
TAL2,
NR4A3 |
behavior [BP],
positive regulation of leukocyte apoptotic process [BP],
bone trabecula formation [BP],
cell migration involved in sprouting angiogenesis [BP],
negative regulation of monocyte chemotaxis [BP],
negative regulation of leukocyte chemotaxis [BP] |
| CG_ffipsc197_promoter_p_RM_12_165_7 |
 |
 |
6 |
1.0 |
2.84E-04 |
DCAF15,
TSPAN17,
RNF169 |
protein ubiquitination [BP] |
| CG_ffipsc197_promoter_p_RM_12_50_6 |
 |
 |
2 |
0.4 |
2.74E-04 |
DIO1,
PIK3C3 |
response to leucine [BP],
thyroxine 5'-deiodinase activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_59_8 |
 |
 |
4 |
0.8 |
3.29E-04 |
ARHGAP10 |
filopodium assembly [BP] |
| CG_ffipsc197_promoter_p_RM_12_85_4 |
 |
 |
2 |
0.4 |
3.32E-04 |
KIAA1967,
PLEKHG6,
IRF4,
GRK5,
PLEKHH1,
FZD7,
APAF1,
ELMO3,
POU3F3 |
positive regulation of interleukin-13 biosynthetic process [BP],
metanephric macula densa development [BP],
regulation of apoptotic process [BP],
negative regulation of ectodermal cell fate specification [BP],
apoptotic process [BP],
phospholipid binding [MF] |
| CG_ffipsc197_promoter_p_RM_12_193_4 |
 |
 |
4 |
0.8 |
2.01E-04 |
BMP1,
TEAD4,
CHRD |
skeletal system development [BP] |
| CG_ffipsc197_promoter_p_RM_12_271_8 |
 |
 |
4 |
0.8 |
8.47E-05 |
PTBP2,
TRIM67,
NTRK1,
FGF2,
DOLPP1 |
developmental programmed cell death [BP],
positive regulation of phospholipase C activity [BP],
response to axon injury [BP],
Ras protein signal transduction [BP],
dolichyldiphosphatase activity [MF],
activation of MAPKK activity [BP],
small GTPase mediated signal transduction [BP],
neurotrophin p75 receptor binding [MF],
positive regulation of neuron projection development [BP],
regulation of neural precursor cell proliferation [BP] |
| CG_ffipsc197_promoter_p_RM_12_178_10 |
 |
 |
5 |
0.8 |
1.38E-04 |
GAD1,
POU3F2 |
neurohypophysis development [BP],
protein-pyridoxal-5-phosphate linkage [BP],
glutamate decarboxylation to succinate [BP],
gamma-aminobutyric acid biosynthetic process [BP],
glutamate decarboxylase activity [MF] |
| CG_ffipsc197_promoter_p_RM_16_1_3 |
 |
 |
11 |
1.0 |
3.80E-04 |
EPHX1,
GNAS,
PNPLA3 |
cis-stilbene-oxide hydrolase activity [MF],
mono-olein transacylation activity [MF],
diolein transacylation activity [MF],
post-embryonic body morphogenesis [BP] |
| CG_ffipsc197_promoter_p_RM_12_62_7 |
 |
 |
2 |
0.4 |
2.99E-04 |
RAC1,
MAP3K1,
PHRF1,
GTF2H4,
FOXO3,
TAF4B,
F10,
TRIP13,
F11 |
positive regulation of actin filament polymerization [BP],
RNA polymerase binding [MF],
oocyte maturation [BP],
blood coagulation, intrinsic pathway [BP],
transcription elongation from RNA polymerase II promoter [BP] |
| CG_ffipsc197_promoter_p_RM_12_16_4 |
 |
 |
3 |
0.6 |
3.97E-04 |
HPN,
TRIM24 |
pilomotor reflex [BP],
perichromatin fibrils [CC],
basement membrane disassembly [BP] |
| CG_ffipsc197_promoter_p_RM_12_163_5 |
 |
 |
3 |
0.6 |
3.19E-04 |
CHD7,
COL13A1 |
collagen type XIII [CC],
skeletal system development [BP] |
| CG_ffipsc197_promoter_p_RM_12_107_4 |
 |
 |
5 |
0.8 |
2.52E-04 |
SOX11,
ATF7IP,
SLC12A5,
BMPR1A,
MXI1,
VLDLR |
positive regulation of osteoblast differentiation [BP],
negative regulation of transcription from RNA polymerase II promoter [BP],
positive regulation of ossification [BP],
neural crest cell development [BP],
thermosensory behavior [BP],
neural plate mediolateral regionalization [BP],
positive regulation of lens epithelial cell proliferation [BP],
paraxial mesoderm structural organization [BP],
positive regulation of hippo signaling cascade [BP] |
| CG_ffipsc197_promoter_p_RM_14_22_3 |
 |
 |
2 |
0.4 |
5.17E-04 |
SIDT1,
LRWD1,
EHMT1 |
chromosome [CC],
RNA transmembrane transporter activity [MF],
dsRNA transport [BP],
telomeric heterochromatin [CC],
establishment of protein localization to chromatin [BP],
chromatin organization [BP] |
| CG_ffipsc197_promoter_p_RM_12_26_4 |
 |
 |
4 |
0.8 |
1.92E-04 |
YY1,
CACNA1G,
DOLPP1 |
dolichyldiphosphatase activity [MF],
response to nickel cation [BP],
response to prostaglandin F stimulus [BP] |
| CG_ffipsc197_promoter_p_RM_12_112_7 |
 |
 |
6 |
1.0 |
1.69E-04 |
FXYD5,
IFRD1,
AQP6 |
adult somatic muscle development [BP],
negative regulation of calcium-dependent cell-cell adhesion [BP],
nitrate transmembrane transporter activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_290_5 |
 |
 |
6 |
1.0 |
2.69E-04 |
GATAD2A,
MAB21L2,
GALNT16 |
embryonic body morphogenesis [BP],
protein glycosylation [BP] |
| CG_ffipsc197_promoter_p_RM_12_65_13 |
 |
 |
5 |
0.8 |
2.68E-04 |
P2RX4 |
positive regulation of calcium ion transport into cytosol [BP] |
| CG_ffipsc197_promoter_p_RM_14_7_2 |
 |
 |
4 |
0.4 |
2.47E-04 |
PDPK1 |
3-phosphoinositide-dependent protein kinase activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_55_5 |
 |
 |
7 |
1.0 |
1.29E-04 |
NCAPD2 |
condensin core heterodimer [CC] |
| CG_ffipsc197_promoter_p_RM_12_179_4 |
 |
 |
3 |
0.4 |
3.25E-04 |
VCL,
PPIA,
MSH2 |
platelet degranulation [BP],
negative regulation of reciprocal meiotic recombination [BP],
uncoating of virus [BP] |
| CG_ffipsc197_promoter_p_RM_14_24_1 |
 |
 |
3 |
0.6 |
1.73E-04 |
IL34 |
macrophage colony-stimulating factor receptor binding [MF] |
| CG_ffipsc197_promoter_p_RM_12_135_8 |
 |
 |
5 |
0.6 |
2.10E-04 |
CFLAR |
negative regulation of myoblast fusion [BP] |
| CG_ffipsc197_promoter_p_RM_12_78_7 |
 |
 |
4 |
0.6 |
3.81E-04 |
DRAXIN |
commissural neuron differentiation in spinal cord [BP] |
| CG_ffipsc197_promoter_p_RM_12_24_7 |
 |
 |
5 |
0.8 |
2.48E-04 |
MAL,
EN2,
PAX2,
ZIC1,
LDLRAP1,
BTRC |
central nervous system development [BP],
amyloid precursor protein metabolic process [BP],
hindbrain development [BP],
inner ear morphogenesis [BP],
protein phosphorylated amino acid binding [MF] |
| CG_ffipsc197_promoter_p_RM_12_213_4 |
 |
 |
3 |
0.6 |
2.10E-04 |
MCM5,
MCM4,
POLA2 |
MCM complex [CC],
DNA replication initiation [BP],
S phase of mitotic cell cycle [BP],
M/G1 transition of mitotic cell cycle [BP],
DNA strand elongation involved in DNA replication [BP] |
| CG_ffipsc197_promoter_p_RM_12_153_13 |
 |
 |
5 |
1.0 |
3.02E-04 |
FGF9,
PAX2,
WNT1 |
inner ear morphogenesis [BP] |
| CG_ffipsc197_promoter_p_RM_12_51_5 |
 |
 |
1 |
0.2 |
9.52E-05 |
DCSTAMP,
CDH4,
PEX13,
PCDH7,
TFAP2C |
positive regulation of macrophage fusion [BP],
microtubule-based peroxisome localization [BP],
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis [BP],
homophilic cell adhesion [BP],
osteoclast fusion [BP],
cerebral cortex development [BP] |
| CG_ffipsc197_promoter_p_RM_12_176_9 |
 |
 |
3 |
0.4 |
4.17E-04 |
CDK5R1 |
cyclin-dependent protein kinase 5 activator activity [MF],
superior olivary nucleus maturation [BP] |
| CG_ffipsc197_promoter_p_RM_12_260_5 |
 |
 |
4 |
0.8 |
3.18E-04 |
ZIC2,
ISL1 |
retinal ganglion cell axon guidance [BP] |
| CG_ffipsc197_promoter_p_RM_12_249_9 |
 |
 |
5 |
0.8 |
3.69E-04 |
AHR |
response to stress [BP] |
| CG_ffipsc197_promoter_p_RM_12_115_13 |
 |
 |
6 |
0.8 |
4.38E-04 |
JAK2,
ELAC1,
BMPR2 |
histone kinase activity (H3-Y41 specific) [MF],
mineralocorticoid receptor signaling pathway [BP],
tRNA 3'-trailer cleavage [BP],
histone H3-Y41 phosphorylation [BP],
caveola [CC],
activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [BP] |
| CG_ffipsc197_promoter_p_RM_12_257_10 |
 |
 |
7 |
0.8 |
1.90E-04 |
BSG |
response to peptide hormone stimulus [BP] |
| CG_ffipsc197_promoter_p_RM_12_244_15 |
 |
 |
7 |
1.0 |
2.97E-04 |
VEGFA,
GABARAPL2,
NNT |
NAD(P)+ transhydrogenase (AB-specific) activity [MF],
basophil chemotaxis [BP],
intra-Golgi vesicle-mediated transport [BP],
NAD(P)+ transhydrogenase (B-specific) activity [MF] |
| CG_ffipsc197_promoter_p_RM_14_8_2 |
 |
 |
5 |
0.6 |
4.00E-05 |
NTRK1 |
neurotrophin p75 receptor binding [MF] |
| CG_ffipsc197_promoter_p_RM_12_159_8 |
 |
 |
2 |
0.4 |
2.58E-04 |
ADCYAP1 |
positive regulation of somatostatin secretion [BP],
negative regulation of acute inflammatory response to non-antigenic stimulus [BP] |
| CG_ffipsc197_promoter_p_RM_12_22_8 |
 |
 |
5 |
0.8 |
1.89E-04 |
CHAT,
HGSNAT |
heparan-alpha-glucosaminide N-acetyltransferase activity [MF],
choline O-acetyltransferase activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_3_9 |
 |
 |
4 |
0.8 |
2.28E-04 |
SIRPA,
RAC1,
SMAD6,
GABRA5,
GATA6,
RHOB,
PKNOX1,
CAPZA2 |
blood coagulation [BP],
cochlea development [BP],
transcription factor complex [CC],
inner ear receptor cell development [BP] |
| CG_ffipsc197_promoter_p_RM_14_3_3 |
 |
 |
7 |
1.0 |
5.72E-04 |
PPP2R1A,
C17orf89,
CCT7,
MRPS30,
PPOX |
peptidyl-serine dephosphorylation [BP],
oxygen-dependent protoporphyrinogen oxidase activity [MF],
mitochondrion [CC] |
| CG_ffipsc197_promoter_p_RM_12_8_3 |
 |
 |
2 |
0.4 |
6.12E-04 |
RPL10A |
RNA metabolic process [BP] |
| CG_ffipsc197_promoter_p_RM_12_199_4 |
 |
 |
4 |
0.8 |
2.82E-04 |
SPATA18,
FGF2,
MIF,
GADD45B |
chemoattractant activity [MF],
phenylpyruvate tautomerase activity [MF],
activation of MAPKK activity [BP],
mitochondrion degradation by induced vacuole formation [BP],
positive regulation of prostaglandin secretion involved in immune response [BP],
positive chemotaxis [BP] |
| CG_ffipsc197_promoter_p_RM_12_211_6 |
 |
 |
4 |
0.8 |
3.73E-04 |
DHRS4,
PIWIL4,
STXBP2 |
alcohol dehydrogenase [NAD(P)+] activity [MF],
gene silencing by RNA [BP],
syntaxin-3 binding [MF] |
| CG_ffipsc197_promoter_p_RM_12_254_4 |
 |
 |
3 |
0.6 |
3.62E-04 |
MPP5 |
protein localization to myelin sheath abaxonal region [BP] |
| CG_ffipsc197_promoter_p_RM_14_1_3 |
 |
 |
13 |
1.0 |
5.56E-04 |
PDE1B,
PGS1,
NPL |
CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [MF],
N-acetylneuraminate lyase activity [MF],
calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_57_6 |
 |
 |
3 |
0.6 |
3.43E-04 |
IGF1R,
PAM,
PRDX5,
AK4,
UBIAD1 |
tetracycline metabolic process [BP],
peroxynitrite reductase activity [MF],
inactivation of MAPKK activity [BP],
carbon tetrachloride metabolic process [BP],
menaquinone biosynthetic process [BP],
protein amidation [BP],
regulation of apoptosis involved in tissue homeostasis [BP],
peptidylamidoglycolate lyase activity [MF],
peptidylglycine monooxygenase activity [MF] |
| CG_ffipsc197_promoter_p_RM_14_28_4 |
 |
 |
7 |
1.0 |
4.67E-04 |
BAG4,
PCYOX1L |
negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [BP],
prenylcysteine catabolic process [BP] |
| CG_ffipsc197_promoter_p_RM_12_28_8 |
 |
 |
4 |
0.8 |
2.82E-04 |
AIP,
FAM20C |
GAF domain binding [MF],
dentinogenesis [BP],
osteoclast maturation [BP] |
| CG_ffipsc197_promoter_p_RM_12_188_9 |
 |
 |
4 |
0.8 |
2.22E-04 |
ARID1A,
ARID2 |
nucleosome disassembly [BP] |
| CG_ffipsc197_promoter_p_RM_12_68_7 |
 |
 |
5 |
0.6 |
2.59E-04 |
RSAD2 |
positive regulation of toll-like receptor 7 signaling pathway [BP],
positive regulation of toll-like receptor 9 signaling pathway [BP] |
| CG_ffipsc197_promoter_p_RM_12_263_9 |
 |
 |
5 |
0.8 |
2.19E-04 |
B4GALNT3 |
N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_90_11 |
 |
 |
3 |
0.6 |
3.06E-04 |
RPS6KA4,
CRTC1 |
positive regulation of CREB transcription factor activity [BP] |
| CG_ffipsc197_promoter_p_RM_14_38_4 |
 |
 |
2 |
0.4 |
4.55E-04 |
CACNA1D |
voltage-gated calcium channel activity involved in regulation of SA node cell action potential [MF],
membrane repolarization involved in regulation of SA node cell action potential [BP],
voltage-gated calcium channel activity involved in regulation of cardiac muscle cell action potential [MF] |
| CG_ffipsc197_promoter_p_RM_12_195_4 |
 |
 |
3 |
0.6 |
3.87E-04 |
ADPRHL2,
BTD |
biotinidase activity [MF],
poly(ADP-ribose) glycohydrolase activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_63_9 |
 |
 |
3 |
0.6 |
2.59E-04 |
TPM1,
PLOD1 |
hydroxylysine biosynthetic process [BP],
positive regulation of heart rate by epinephrine [BP] |
| CG_ffipsc197_promoter_p_RM_12_69_9 |
 |
 |
6 |
0.8 |
4.27E-04 |
PIN1,
NUP50,
DSP,
CDC7,
ATF4 |
phosphothreonine binding [MF],
nucleoplasm [CC],
ventricular compact myocardium morphogenesis [BP] |
| CG_ffipsc197_promoter_p_RM_14_43_3 |
 |
 |
4 |
0.6 |
5.33E-04 |
NAT8L,
NRTN,
ISL1 |
neural crest cell migration [BP],
nerve development [BP],
aspartate N-acetyltransferase activity [MF] |
| CG_ffipsc197_promoter_p_RM_12_15_6 |
 |
 |
3 |
0.6 |
2.39E-04 |
CHRD,
HELT,
SOX11 |
positive regulation of lens epithelial cell proliferation [BP],
spinal cord development [BP],
BMP signaling pathway involved in spinal cord dorsal/ventral patterning [BP],
GABAergic neuron differentiation in basal ganglia [BP],
positive regulation of hippo signaling cascade [BP] |
| CG_ffipsc197_promoter_p_RM_12_278_4 |
 |
 |
1 |
0.2 |
2.86E-04 |
HM13,
MSRB3,
SEC61A1,
CD4 |
endoplasmic reticulum [CC],
rough endoplasmic reticulum [CC],
protein palmitoleylation [BP],
induction by virus of host cell-cell fusion [BP] |
| CG_ffipsc197_promoter_p_RM_12_203_10 |
 |
 |
5 |
1.0 |
2.32E-04 |
ATL1,
TPGS1 |
axon [CC] |
| CG_ffipsc197_promoter_p_RM_12_18_5 |
 |
 |
4 |
0.6 |
2.84E-04 |
AGPAT6 |
glandular epithelial cell maturation [BP] |
| CG_ffipsc197_promoter_p_RM_12_93_8 |
 |
 |
5 |
0.6 |
1.76E-04 |
GCDH,
MIOX |
glutaryl-CoA dehydrogenase activity [MF],
inositol oxygenase activity [MF],
inositol catabolic process [BP] |
| CG_ffipsc197_promoter_p_RM_14_12_4 |
 |
 |
3 |
0.4 |
4.23E-04 |
SSH3,
RAC1,
GABRA5 |
regulation of lamellipodium assembly [BP],
cerebral cortex radially oriented cell migration [BP],
cochlea development [BP],
inner ear receptor cell development [BP],
hyperosmotic response [BP] |
| CG_ffipsc197_promoter_p_RM_12_174_4 |
 |
 |
5 |
1.0 |
3.00E-04 |
EXOSC2 |
exosome (RNase complex) [CC] |
| CG_ffipsc197_promoter_p_RM_12_169_7 |
 |
 |
3 |
0.6 |
2.28E-05 |
PICK1,
IFRD1,
GNAS,
PRRC2C |
mu-type opioid receptor binding [MF],
post-embryonic body morphogenesis [BP],
myoblast cell fate determination [BP],
DNA methylation [BP],
adult somatic muscle development [BP],
protein C-terminus binding [MF] |
| CG_ffipsc197_promoter_p_RM_12_265_6 |
 |
 |
4 |
0.6 |
4.52E-04 |
SKIL,
TRAF2 |
protein homotrimerization [BP] |
| CG_ffipsc197_promoter_p_RM_12_170_12 |
 |
 |
4 |
0.6 |
3.02E-04 |
FOXL1,
SALL3 |
forelimb morphogenesis [BP],
visceral mesoderm-endoderm interaction involved in midgut development [BP] |
| CG_ffipsc197_promoter_p_RM_12_61_7 |
 |
 |
5 |
0.8 |
3.40E-04 |
OGG1 |
regulation of protein import into nucleus, translocation [BP] |